Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Santus

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Internal Medicine|August 26, 2016
The old open question of marijuana and healthcare: Flares from NANHESP Santus, D Radovanovic
Pharmacological Research|January 5, 2005
Effects of salmeterol on cilia and mucus in COPD and pneumonia patientsG Piatti, U Ambrosetti, P Santus, et al.
Soins; La Revue De Reference Infirmiere|July 1, 1990
[Implantable vascular access ports. Use and maintenance]A Deroux, C Rieu, C Bouye, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 8, 2013
Varenicline and evaluated outcomes in smoking cessation programmesP Santus, L Bassi, A Airoldi, et al.
Minerva Medica|April 23, 2015
Bronchoscopy in sarcoidosis: union is strengthM Mondoni, D Radovanovic, V Valenti, et al.
Minerva Medica|July 5, 2014
Is mild asthma in real life always in the Green Zone?V Patella, P Santus, F Puggioni, et al.
European Review for Medical and Pharmacological Sciences|February 25, 2014
The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damageF Di Marco, F Braido, P Santus, et al.
Minerva Medica|November 20, 2015
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthmaC Calabrese, G E Carpagnano, V Patella, et al.
Minerva Medica|July 19, 2016
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma?C Calabrese, G E Carpagnano, V Patella, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1982
[Signs of possible malignant changes in mastopathies: recognition and treatment ]J Reynier, M Mogenet, J P Santus, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Internal Medicine|August 26, 2016
The old open question of marijuana and healthcare: Flares from NANHESP Santus, D Radovanovic
Pharmacological Research|January 5, 2005
Effects of salmeterol on cilia and mucus in COPD and pneumonia patientsG Piatti, U Ambrosetti, P Santus, et al.
Soins; La Revue De Reference Infirmiere|July 1, 1990
[Implantable vascular access ports. Use and maintenance]A Deroux, C Rieu, C Bouye, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 8, 2013
Varenicline and evaluated outcomes in smoking cessation programmesP Santus, L Bassi, A Airoldi, et al.
Minerva Medica|April 23, 2015
Bronchoscopy in sarcoidosis: union is strengthM Mondoni, D Radovanovic, V Valenti, et al.
Minerva Medica|July 5, 2014
Is mild asthma in real life always in the Green Zone?V Patella, P Santus, F Puggioni, et al.
European Review for Medical and Pharmacological Sciences|February 25, 2014
The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damageF Di Marco, F Braido, P Santus, et al.
Minerva Medica|November 20, 2015
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthmaC Calabrese, G E Carpagnano, V Patella, et al.
Minerva Medica|July 19, 2016
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma?C Calabrese, G E Carpagnano, V Patella, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1982
[Signs of possible malignant changes in mastopathies: recognition and treatment ]J Reynier, M Mogenet, J P Santus, et al.
Pageof 6